TP53 and lung cancer: developed dual‐targeted hyaluronic acid‐based nanoparticles‐encapsulating wt‐p53 and miR‐125b to transfect the KRAS/p53 mutant SK‐LU‐1 non‐small cell lung cancer (NSCLC) cells.[137] They found that the SK‐LU‐1‐isloated exosomes also could transfer TAMs into M1 profiles.